Terms: = Ovarian cancer AND DDX5, HLR1, 1655, ENSG00000108654, P17844, DKFZp686J01190, p68, G17P1, HUMP68 AND Treatment
5 results:
1. The feedback loop of AURKA/ddx5/TMEM147-AS1/let-7 drives lipophagy to induce cisplatin resistance in epithelial ovarian cancer.
Shao Y; Li H; Wu Y; Wang X; Meng J; Hu Z; Xia L; Cao S; Tian W; Zhang Y; Feng X; Zhang X; Li Y; Yang G
Cancer Lett; 2023 Jul; 565():216241. PubMed ID: 37217070
[TBL] [Abstract] [Full Text] [Related]
2. ovarian teratoma-associated anti-N-methyl-D-aspartate receptor encephalitis: a clinical analysis of 5 cases.
He LD; Zhang X; Wu J
Ginekol Pol; 2023; 94(6):451-455. PubMed ID: 36597802
[TBL] [Abstract] [Full Text] [Related]
3. Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study.
Lee JM; Nair J; Zimmer A; Lipkowitz S; Annunziata CM; Merino MJ; Swisher EM; Harrell MI; Trepel JB; Lee MJ; Bagheri MH; Botesteanu DA; Steinberg SM; Minasian L; Ekwede I; Kohn EC
Lancet Oncol; 2018 Feb; 19(2):207-215. PubMed ID: 29361470
[TBL] [Abstract] [Full Text] [Related]
4. [Effect of trastuzumab on tumor cell lines shedding high or low level of HER-2 ECD].
Liu CY; Yang W; Li JF; Sun SL; Shou CC
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):101-5. PubMed ID: 17645842
[TBL] [Abstract] [Full Text] [Related]
5. Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q.
Stone B; Schummer M; Paley PJ; Thompson L; Stewart J; Ford M; Crawford M; Urban N; O'Briant K; Nelson BH
Int J Cancer; 2003 Mar; 104(1):73-84. PubMed ID: 12532422
[TBL] [Abstract] [Full Text] [Related]
